The US Branded Generics market is gaining opportunities in chronic disease treatment, including cardiovascular and metabolic conditions. Demand for long-term medication supports recurring prescriptions, encouraging manufacturers to maintain dependable supply and develop portfolios that meet established treatment needs. The Branded Generics Market was valued at US$ 258.85 billion in 2023 and is...